# COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

> **NCT05584176** · NA · COMPLETED · sponsor: **MP Biomedicals, LLC** · enrollment: 332 (actual)

## Conditions studied

- SARS-CoV2 Infection
- COVID-19

## Interventions

- **DEVICE:** iCura COVID-19 Antigen Rapid Home Test
- **DEVICE:** RT-PCR Test

## Key facts

- **NCT ID:** NCT05584176
- **Lead sponsor:** MP Biomedicals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-09
- **Primary completion:** 2022-01-21
- **Final completion:** 2022-01-21
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2023-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584176, "COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05584176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*